<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://cat.sagepub.com/">
<title>Clin Appl Thromb Hemost: Most-Read Full-Text Articles</title>
<link>http://cat.sagepub.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2009-11-06</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/163?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609343004v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/377?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/389?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/8/1/1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609344199v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609347900v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609349500v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609340668v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/125?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/353?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/443?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609342093v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/1/19?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/4/389?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/3/378?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/422?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/14/2/245?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/395?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609344427v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/391?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/2/152?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609344588v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/205?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/410?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609349501v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609335912v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609338044v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609338711v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609344981v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609345686v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/169?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/362?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/13/4/435?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/465?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/185?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/3/270?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609342094v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609343706v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609348313v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/448?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/470?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029608322547v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/2/137?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/12/3/254?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/14/4/385?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/15/4/402?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609335517v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/1076029609344085v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cat.sagepub.com/cgi/content/short/10/2/89?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/163?rss=1&amp;ssource=mfc">
<title><![CDATA[The Role of Adiponectin in Atherosclerosis and Thrombosis]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/163?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hakan Ekmekci, Ozlem B. Ekmekci<br />Apr  1, 2006; 12:163-168<br />Article]]></description>
<dc:creator>Hakan Ekmekci, Ozlem B. Ekmekci</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200203</dc:identifier>
<dc:title><![CDATA[The Role of Adiponectin in Atherosclerosis and Thrombosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609343004v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609343004v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Joachim Stangier, PhD, Andreas Clemens<br />Aug 19, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Joachim Stangier, PhD, Andreas Clemens</dc:creator>
<dc:date>2009-08-19</dc:date>
<dc:title><![CDATA[Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/377?rss=1&amp;ssource=mfc">
<title><![CDATA[State-of-the-Art Review: Assessing the Safety Profiles of New Anticoagulants for Major Orthopedic Surgery Thromboprophylaxis]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/377?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Russell D. Hull, Roger D. Yusen, David Bergqvist<br />Aug  1, 2009; 15:377-388<br />Article]]></description>
<dc:creator>Russell D. Hull, Roger D. Yusen, David Bergqvist</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[State-of-the-Art Review: Assessing the Safety Profiles of New Anticoagulants for Major Orthopedic Surgery Thromboprophylaxis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/389?rss=1&amp;ssource=mfc">
<title><![CDATA[Interpretation of Benefit-Risk of Enoxaparin as Comparator in the RECORD Program: Rivaroxaban Oral Tablets (10 milligrams) for Use in Prophylaxis in Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Hip or Knee Replacement Surgery]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/389?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David Van Thiel, Evi Kalodiki, Rakesh Wahi, Evan Litinas, Wasimul Haque, Gundu Rao<br />Aug  1, 2009; 15:389-394<br />Article]]></description>
<dc:creator>David Van Thiel, Evi Kalodiki, Rakesh Wahi, Evan Litinas, Wasimul Haque, Gundu Rao</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Interpretation of Benefit-Risk of Enoxaparin as Comparator in the RECORD Program: Rivaroxaban Oral Tablets (10 milligrams) for Use in Prophylaxis in Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Hip or Knee Replacement Surgery]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/8/1/1?rss=1&amp;ssource=mfc">
<title><![CDATA[Disseminated Intravascular Coagulation: A Review of Etiology, Pathophysiology, Diagnosis, and Management: Guidelines for Care]]></title>
<link>http://cat.sagepub.com/cgi/content/short/8/1/1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rodger L. Bick<br />Jan  1, 2002; 8:1-31<br />Article]]></description>
<dc:creator>Rodger L. Bick</dc:creator>
<dc:date>2002-01-01</dc:date>
<dc:identifier>10.1177/107602960200800103</dc:identifier>
<dc:title><![CDATA[Disseminated Intravascular Coagulation: A Review of Etiology, Pathophysiology, Diagnosis, and Management: Guidelines for Care]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609344199v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Dabigatran Etexilate: Future Directions in Anticoagulant Treatment]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609344199v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sam Schulman, MD, PhD, Paul A. Reilly<br />Aug 13, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Sam Schulman, MD, PhD, Paul A. Reilly</dc:creator>
<dc:date>2009-08-13</dc:date>
<dc:title><![CDATA[Dabigatran Etexilate: Future Directions in Anticoagulant Treatment]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609347900v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Fondaparinux for the Treatment of Acute Heparin-Induced Thrombocytopenia: A Single-Center Experience]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609347900v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Elisavet Grouzi, Consultant Haematologist, Elias Kyriakou, Ioannis Panagou, Ioanna Spiliotopoulou<br />Oct 13, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Elisavet Grouzi, Consultant Haematologist, Elias Kyriakou, Ioannis Panagou, Ioanna Spiliotopoulou</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[Fondaparinux for the Treatment of Acute Heparin-Induced Thrombocytopenia: A Single-Center Experience]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609349500v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Anticoagulants for Acute Venous Thromboembolism: What We Think We Know and What the Data Show for Timing of Recurrent Events]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609349500v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Paul D. Stein, MD, Russell D. Hull, Fadi Matta, Abdo Y. Yaekoub<br />Oct 13, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Paul D. Stein, MD, Russell D. Hull, Fadi Matta, Abdo Y. Yaekoub</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[Anticoagulants for Acute Venous Thromboembolism: What We Think We Know and What the Data Show for Timing of Recurrent Events]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609340668v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Dabigatran Etexilate: Pivotal Trials for Venous Thromboembolism Prophylaxis After Hip or Knee Arthroplasty]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609340668v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bengt I. Eriksson, Richard Friedman, MD<br />Jul 31, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Bengt I. Eriksson, Richard Friedman, MD</dc:creator>
<dc:date>2009-07-31</dc:date>
<dc:title><![CDATA[Dabigatran Etexilate: Pivotal Trials for Venous Thromboembolism Prophylaxis After Hip or Knee Arthroplasty]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/125?rss=1&amp;ssource=mfc">
<title><![CDATA[Hereditary and Acquired Thrombophilic Disorders]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/125?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rodger L. Bick<br />Apr  1, 2006; 12:125-135<br />Article]]></description>
<dc:creator>Rodger L. Bick</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200201</dc:identifier>
<dc:title><![CDATA[Hereditary and Acquired Thrombophilic Disorders]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/353?rss=1&amp;ssource=mfc">
<title><![CDATA[Argatroban Therapy for Heparin-Induced Thrombocytopenia in Acutely Ill Patients]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/353?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Anthony Gray, Diane E. Wallis, Marcie J. Hursting, Eliezer Katz, Bruce E. Lewis<br />Oct  1, 2007; 13:353-361<br />Article]]></description>
<dc:creator>Anthony Gray, Diane E. Wallis, Marcie J. Hursting, Eliezer Katz, Bruce E. Lewis</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303617</dc:identifier>
<dc:title><![CDATA[Argatroban Therapy for Heparin-Induced Thrombocytopenia in Acutely Ill Patients]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/443?rss=1&amp;ssource=mfc">
<title><![CDATA[Acquired Hemophilia: A Case Report of 2 Patients With Acquired Factor VIII Inhibitor Treated With Rituximab Plus a Short Course of Steroid and Review of the Literature]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/443?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yesid Alvarado,   Xin Yao, Cynthia Jumper, Fred Hardwicke, Nicholas D''Cunha, Everardo Cobos<br />Oct  1, 2007; 13:443-448<br />Article]]></description>
<dc:creator>Yesid Alvarado,   Xin Yao, Cynthia Jumper, Fred Hardwicke, Nicholas D''Cunha, Everardo Cobos</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303777</dc:identifier>
<dc:title><![CDATA[Acquired Hemophilia: A Case Report of 2 Patients With Acquired Factor VIII Inhibitor Treated With Rituximab Plus a Short Course of Steroid and Review of the Literature]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609342093v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Early Discharge of Patients With Venous Thromboembolism: Implications Regarding Therapy]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609342093v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Paul D. Stein, MD, Russell D. Hull, Fadi Matta, Abdo Y. Yaekoub<br />Oct 14, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Paul D. Stein, MD, Russell D. Hull, Fadi Matta, Abdo Y. Yaekoub</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Early Discharge of Patients With Venous Thromboembolism: Implications Regarding Therapy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/1/19?rss=1&amp;ssource=mfc">
<title><![CDATA[Central Venous Catheterization: A Prospective, Randomized, Double-Blind Study]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/1/19?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Mervyn Mer, Adriano Gianmaria Duse, Jacqueline Suzanne Galpin, Guy Antony Richards<br />Feb  1, 2009; 15:19-26<br />Article]]></description>
<dc:creator>Mervyn Mer, Adriano Gianmaria Duse, Jacqueline Suzanne Galpin, Guy Antony Richards</dc:creator>
<dc:date>2009-02-01</dc:date>
<dc:title><![CDATA[Central Venous Catheterization: A Prospective, Randomized, Double-Blind Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/4/389?rss=1&amp;ssource=mfc">
<title><![CDATA[Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/4/389?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Steven R. Deitcher, Craig M. Kessler, Geno Merli, James R. Rigas, Roger M. Lyons, Jawed Fareed<br />Oct  1, 2006; 12:389-396<br />Article]]></description>
<dc:creator>Steven R. Deitcher, Craig M. Kessler, Geno Merli, James R. Rigas, Roger M. Lyons, Jawed Fareed</dc:creator>
<dc:date>2006-10-01</dc:date>
<dc:identifier>10.1177/1076029606293692</dc:identifier>
<dc:title><![CDATA[Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/3/378?rss=1&amp;ssource=mfc">
<title><![CDATA[Is Yasmin as Safe as Other Contraceptive Pills?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/3/378?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yolanda Mira, Carmen Morata, Amparo Vaya, Fernando Ferrando, Teresa Contreras, Justo Aznar<br />Jul  1, 2006; 12:378-379<br />Article]]></description>
<dc:creator>Yolanda Mira, Carmen Morata, Amparo Vaya, Fernando Ferrando, Teresa Contreras, Justo Aznar</dc:creator>
<dc:date>2006-07-01</dc:date>
<dc:identifier>10.1177/1076029606291424</dc:identifier>
<dc:title><![CDATA[Is Yasmin as Safe as Other Contraceptive Pills?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/422?rss=1&amp;ssource=mfc">
<title><![CDATA[Hypercoagulable State in Five Thalassemia Intermedia Patients]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/422?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Maitreyee Bhattacharyya, Meganathan Kannan, Ved P. Chaudhry, M. Mahapatra, H. Pati, Renu Saxena<br />Oct  1, 2007; 13:422-427<br />Article]]></description>
<dc:creator>Maitreyee Bhattacharyya, Meganathan Kannan, Ved P. Chaudhry, M. Mahapatra, H. Pati, Renu Saxena</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303539</dc:identifier>
<dc:title><![CDATA[Hypercoagulable State in Five Thalassemia Intermedia Patients]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/14/2/245?rss=1&amp;ssource=mfc">
<title><![CDATA[The Safety Profile of Yasmin Is Similar to Other Combined Oral Contraceptives]]></title>
<link>http://cat.sagepub.com/cgi/content/short/14/2/245?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Maureen Cronin, Paul Korner<br />Apr  1, 2008; 14:245-246<br />Article]]></description>
<dc:creator>Maureen Cronin, Paul Korner</dc:creator>
<dc:date>2008-04-01</dc:date>
<dc:identifier>10.1177/1076029607310219</dc:identifier>
<dc:title><![CDATA[The Safety Profile of Yasmin Is Similar to Other Combined Oral Contraceptives]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/395?rss=1&amp;ssource=mfc">
<title><![CDATA[Isolation and Characterization of Contaminants in Recalled Unfractionated Heparin and Low-Molecular-Weight Heparin]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/395?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christian Viskov, E. Bouley, P. Hubert, Celine Martinez, F. Herman, Walter Jeske, Debra Hoppensteadt, Jeanine M. Walenga, Jawed Fareed<br />Aug  1, 2009; 15:395-401<br />Article]]></description>
<dc:creator>Christian Viskov, E. Bouley, P. Hubert, Celine Martinez, F. Herman, Walter Jeske, Debra Hoppensteadt, Jeanine M. Walenga, Jawed Fareed</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Isolation and Characterization of Contaminants in Recalled Unfractionated Heparin and Low-Molecular-Weight Heparin]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609344427v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609344427v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Russell D. Hull<br />Aug 24, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Russell D. Hull</dc:creator>
<dc:date>2009-08-24</dc:date>
<dc:title><![CDATA[Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/391?rss=1&amp;ssource=mfc">
<title><![CDATA[Elevated Concentrations of Soluble Adhesion Molecules and Large Platelets in Diabetic Patients: Are They Markers of Vascular Disease and Diabetic Nephropathy?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/391?rss=1&amp;ssource=mfc</link>
<description><![CDATA[N. Bavbek, A. Kargili, O. Kaftan, F. Karakurt, A. Kosar, A. Akcay<br />Oct  1, 2007; 13:391-397<br />Article]]></description>
<dc:creator>N. Bavbek, A. Kargili, O. Kaftan, F. Karakurt, A. Kosar, A. Akcay</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303615</dc:identifier>
<dc:title><![CDATA[Elevated Concentrations of Soluble Adhesion Molecules and Large Platelets in Diabetic Patients: Are They Markers of Vascular Disease and Diabetic Nephropathy?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/2/152?rss=1&amp;ssource=mfc">
<title><![CDATA[Glanzmann's Thrombasthenia: An Overview]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/2/152?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Meganathan Kannan, Renu Saxena<br />Apr  1, 2009; 15:152-165<br />Original Articles]]></description>
<dc:creator>Meganathan Kannan, Renu Saxena</dc:creator>
<dc:date>2009-04-01</dc:date>
<dc:title><![CDATA[Glanzmann's Thrombasthenia: An Overview]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609344588v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Dabigatran Etexilate for the Prophylaxis of Venous Thromboembolism After Hip or Knee Replacement: Rationale for Dose Regimen]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609344588v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ola E. Dahl, MD, PhD<br />Aug 19, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Ola E. Dahl, MD, PhD</dc:creator>
<dc:date>2009-08-19</dc:date>
<dc:title><![CDATA[Dabigatran Etexilate for the Prophylaxis of Venous Thromboembolism After Hip or Knee Replacement: Rationale for Dose Regimen]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/205?rss=1&amp;ssource=mfc">
<title><![CDATA[Comparison of Pycnogenol(R) and Daflon(R) in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/205?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, G. Acerbi, M. Cacchio, A. Di Renzo, M. Hosoi, S. Stuard, M. Corsi<br />Apr  1, 2006; 12:205-212<br />Article]]></description>
<dc:creator>M. R. Cesarone, G. Belcaro, P. Rohdewald, L. Pellegrini, A. Ledda, G. Vinciguerra, A. Ricci, G. Gizzi, E. Ippolito, F. Fano, M. Dugall, G. Acerbi, M. Cacchio, A. Di Renzo, M. Hosoi, S. Stuard, M. Corsi</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200209</dc:identifier>
<dc:title><![CDATA[Comparison of Pycnogenol(R) and Daflon(R) in Treating Chronic Venous Insufficiency: A Prospective, Controlled Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/410?rss=1&amp;ssource=mfc">
<title><![CDATA[Soluble P-Selectin During a Single Hemodialysis Session in Patients With Chronic Renal Failure and Erythropoietin Treatment]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/410?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jan Stasko, Peter Galajda, Jela Ivankova, Pavol Holly, Eva Rozborilova, Peter Kubisz<br />Oct  1, 2007; 13:410-415<br />Article]]></description>
<dc:creator>Jan Stasko, Peter Galajda, Jela Ivankova, Pavol Holly, Eva Rozborilova, Peter Kubisz</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303348</dc:identifier>
<dc:title><![CDATA[Soluble P-Selectin During a Single Hemodialysis Session in Patients With Chronic Renal Failure and Erythropoietin Treatment]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609349501v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of Atenolol or Losartan on Fibrinolysis and von Willebrand Factor in Hypertensive Patients With Left Ventricular Hypertrophy]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609349501v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kurt Boman, Jenny Hernestal Boman, Jonas Andersson, Mona Olofsson, Bjorn Dahlof<br />Oct 13, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Kurt Boman, Jenny Hernestal Boman, Jonas Andersson, Mona Olofsson, Bjorn Dahlof</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[Effects of Atenolol or Losartan on Fibrinolysis and von Willebrand Factor in Hypertensive Patients With Left Ventricular Hypertrophy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609335912v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an in Vivo Rabbit Experimental Model]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609335912v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hasan Bilgili, Ozge Captug, Ali Kosar, Mevlut Kurt, Murat Kekilli, Ali Shorbagi, Ozlem Kar Kurt, Oktay Ozdemir, Hakan Goker, Ibrahim Haznedaroglu<br />Jul 14, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Hasan Bilgili, Ozge Captug, Ali Kosar, Mevlut Kurt, Murat Kekilli, Ali Shorbagi, Ozlem Kar Kurt, Oktay Ozdemir, Hakan Goker, Ibrahim Haznedaroglu</dc:creator>
<dc:date>2009-07-14</dc:date>
<dc:title><![CDATA[Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an in Vivo Rabbit Experimental Model]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609338044v1?rss=1&amp;ssource=mfc">
<title><![CDATA[A Comparison of the Biological Activity of 2 Formulations of Enoxaparin in 12 Healthy Volunteers]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609338044v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Vineeta Sharma, Sirisha Madhu, Parthiban N, Ganesan M, Vijaya Jaiswal, Renu Saxena<br />Aug 10, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Vineeta Sharma, Sirisha Madhu, Parthiban N, Ganesan M, Vijaya Jaiswal, Renu Saxena</dc:creator>
<dc:date>2009-08-10</dc:date>
<dc:title><![CDATA[A Comparison of the Biological Activity of 2 Formulations of Enoxaparin in 12 Healthy Volunteers]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609338711v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Comparative Anticoagulant and Platelet Modulatory Effects of Enoxaparin and Sulodexide]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609338711v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Cafer Adiguzel, Omer Iqbal, Debra Hoppensteadt, Walter Jeske, PhD, Josephine Cunanan, Evangelos Litinas, He Zhu, Jeanine M. Walenga, Jawed Fareed<br />Aug 23, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Cafer Adiguzel, Omer Iqbal, Debra Hoppensteadt, Walter Jeske, PhD, Josephine Cunanan, Evangelos Litinas, He Zhu, Jeanine M. Walenga, Jawed Fareed</dc:creator>
<dc:date>2009-08-23</dc:date>
<dc:title><![CDATA[Comparative Anticoagulant and Platelet Modulatory Effects of Enoxaparin and Sulodexide]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609344981v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Tissue Factor Pathway Inhibitor and P-Selectin as Markers of Sepsis-Induced Non-overt Disseminated Intravascular Coagulopathy]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609344981v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Eman Mosad, MD, Khalid I. Elsayh, Azza A. Eltayeb<br />Aug 18, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Eman Mosad, MD, Khalid I. Elsayh, Azza A. Eltayeb</dc:creator>
<dc:date>2009-08-18</dc:date>
<dc:title><![CDATA[Tissue Factor Pathway Inhibitor and P-Selectin as Markers of Sepsis-Induced Non-overt Disseminated Intravascular Coagulopathy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609345686v1?rss=1&amp;ssource=mfc">
<title><![CDATA[FXa Inhibition and Coagulation Changes During DVT Prophylaxis by Enoxaparin Over the Course of a 15-Day Follow-Up in Septic Patients]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609345686v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Zuzana Zenahlikova, Jan Kvasnicka, Zuzana Kudrnova, Magda Sudrova, Radka Brzezkova, Jiri Mazoch, Ivana Malikova, Josef Vyborny, David Erhart, Ladislav Pecen<br />Oct 22, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Zuzana Zenahlikova, Jan Kvasnicka, Zuzana Kudrnova, Magda Sudrova, Radka Brzezkova, Jiri Mazoch, Ivana Malikova, Josef Vyborny, David Erhart, Ladislav Pecen</dc:creator>
<dc:date>2009-10-22</dc:date>
<dc:title><![CDATA[FXa Inhibition and Coagulation Changes During DVT Prophylaxis by Enoxaparin Over the Course of a 15-Day Follow-Up in Septic Patients]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/169?rss=1&amp;ssource=mfc">
<title><![CDATA[Vitamin E and a-Lipoic Acid Supplementation Increase Bleeding Tendency via an Intrinsic Coagulation Pathway]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/169?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Susan A. Marsh, Jeff S. Coombes<br />Apr  1, 2006; 12:169-173<br />Article]]></description>
<dc:creator>Susan A. Marsh, Jeff S. Coombes</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200204</dc:identifier>
<dc:title><![CDATA[Vitamin E and a-Lipoic Acid Supplementation Increase Bleeding Tendency via an Intrinsic Coagulation Pathway]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/362?rss=1&amp;ssource=mfc">
<title><![CDATA[Plasma Thrombin Activatable Fibrinolysis Inhibitor and Tissue Factor Pathway Inhibitor Changes Following Sepsis]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/362?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thyyar M. Ravindranath, Masakatsu Goto, Omer Iqbal, Michelle Florian-Kujawski, Debra Hoppensteadt, Rashid Hammadeh, Mohammad M. Sayeed, J. Fareed<br />Oct  1, 2007; 13:362-368<br />Article]]></description>
<dc:creator>Thyyar M. Ravindranath, Masakatsu Goto, Omer Iqbal, Michelle Florian-Kujawski, Debra Hoppensteadt, Rashid Hammadeh, Mohammad M. Sayeed, J. Fareed</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607305580</dc:identifier>
<dc:title><![CDATA[Plasma Thrombin Activatable Fibrinolysis Inhibitor and Tissue Factor Pathway Inhibitor Changes Following Sepsis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/13/4/435?rss=1&amp;ssource=mfc">
<title><![CDATA[Molecular Analysis of Factor V Leiden, Factor V Hong Kong, Factor II G20210A, Methylenetetrahydrofolate Reductase C677T, and A1298C Mutations Related to Turkish Thrombosis Patients]]></title>
<link>http://cat.sagepub.com/cgi/content/short/13/4/435?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bilgen Dolek, Serpil Eraslan, Sevim Eroglu, Belgin Eroglu Kesim, Turgut Ulutin, Altan Yalciner, Yahya R. Laleli, Nermin Gozukirmizi<br />Oct  1, 2007; 13:435-438<br />Article]]></description>
<dc:creator>Bilgen Dolek, Serpil Eraslan, Sevim Eroglu, Belgin Eroglu Kesim, Turgut Ulutin, Altan Yalciner, Yahya R. Laleli, Nermin Gozukirmizi</dc:creator>
<dc:date>2007-10-01</dc:date>
<dc:identifier>10.1177/1076029607303341</dc:identifier>
<dc:title><![CDATA[Molecular Analysis of Factor V Leiden, Factor V Hong Kong, Factor II G20210A, Methylenetetrahydrofolate Reductase C677T, and A1298C Mutations Related to Turkish Thrombosis Patients]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/465?rss=1&amp;ssource=mfc">
<title><![CDATA[Pericardial Hemorrhage Due to Acetylsalicylic Acid in a Patient With Essential Thrombocythemia]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/465?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Mehmet Kayrak, Kadir Acar, Mehmet Yazici, Coskun Kaya, S. Selim Ayhan, Hasan Gok<br />Aug  1, 2009; 15:465-466<br />Article]]></description>
<dc:creator>Mehmet Kayrak, Kadir Acar, Mehmet Yazici, Coskun Kaya, S. Selim Ayhan, Hasan Gok</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Pericardial Hemorrhage Due to Acetylsalicylic Acid in a Patient With Essential Thrombocythemia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/185?rss=1&amp;ssource=mfc">
<title><![CDATA[Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/185?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Takeshi Matsumoto, Hideo Wada, Yukiko Nishioka, Midori Nishio, Yasunori Abe, Junji Nishioka, Yuko Kamikura, Tomohiro Sase, Toshihiro Kaneko, Wim P. M. Houdijk, Tsutomu Nobori, Hiroshi Shiku<br />Apr  1, 2006; 12:185-192<br />Article]]></description>
<dc:creator>Takeshi Matsumoto, Hideo Wada, Yukiko Nishioka, Midori Nishio, Yasunori Abe, Junji Nishioka, Yuko Kamikura, Tomohiro Sase, Toshihiro Kaneko, Wim P. M. Houdijk, Tsutomu Nobori, Hiroshi Shiku</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200206</dc:identifier>
<dc:title><![CDATA[Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/3/270?rss=1&amp;ssource=mfc">
<title><![CDATA[In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/3/270?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Handan S. Cipil, Ali Kosar, Arif Kaya, Burak Uz, Ibrahim C. Haznedaroglu, Hakan Goker, Oktay Ozdemir, Mustafa Koroglu, Serafettin Kirazli, Huseyin Cahit Firat<br />Jun  1, 2009; 15:270-276<br />Article]]></description>
<dc:creator>Handan S. Cipil, Ali Kosar, Arif Kaya, Burak Uz, Ibrahim C. Haznedaroglu, Hakan Goker, Oktay Ozdemir, Mustafa Koroglu, Serafettin Kirazli, Huseyin Cahit Firat</dc:creator>
<dc:date>2009-06-01</dc:date>
<dc:title><![CDATA[In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609342094v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Rivaroxaban in Orthopedic Surgery: A Change of Paradigm?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609342094v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sam Schulman, MD, PhD<br />Aug 10, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Sam Schulman, MD, PhD</dc:creator>
<dc:date>2009-08-10</dc:date>
<dc:title><![CDATA[Rivaroxaban in Orthopedic Surgery: A Change of Paradigm?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609343706v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609343706v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Berat Z. Haznedaroglu, MSc, Ibrahim C. Haznedaroglu, Sharon L. Walker, Hasan Bilgili, Hakan Goker, Ali Kosar, Alper Aktas, dr, Ozge Captug, Mevlut Kurt, Oktay Ozdemir, Serafettin Kirazli, Huseyin C. Firat<br />Oct 14, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Berat Z. Haznedaroglu, MSc, Ibrahim C. Haznedaroglu, Sharon L. Walker, Hasan Bilgili, Hakan Goker, Ali Kosar, Alper Aktas, dr, Ozge Captug, Mevlut Kurt, Oktay Ozdemir, Serafettin Kirazli, Huseyin C. Firat</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609348313v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Candidate Genes of Cerebrovascular Disease and Sudden Sensorineural Hearing Loss]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609348313v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jae-Young Um, Chul-Ho Jang, Kyu-Yeop Kim, Su-Jin Kim, Na-Hyung Kim, Phil-Dong Moon, In-Young Choi, Noh-Yil Myung, Hyun-Ja Jeong, Seung-Heon Hong, Hyung-Min Kim, PhD<br />Oct 14, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Jae-Young Um, Chul-Ho Jang, Kyu-Yeop Kim, Su-Jin Kim, Na-Hyung Kim, Phil-Dong Moon, In-Young Choi, Noh-Yil Myung, Hyun-Ja Jeong, Seung-Heon Hong, Hyung-Min Kim, PhD</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Candidate Genes of Cerebrovascular Disease and Sudden Sensorineural Hearing Loss]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/448?rss=1&amp;ssource=mfc">
<title><![CDATA[Patterns of Acquired Bleeding Disorders in a Tertiary Care Hospital]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/448?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bhushan Asthana, Prashant Sharma, Ravi Ranjan, Prachi Jain, Ajisha Aravindan, Pravas Chandra Mishra, Renu Saxena<br />Aug  1, 2009; 15:448-453<br />Article]]></description>
<dc:creator>Bhushan Asthana, Prashant Sharma, Ravi Ranjan, Prachi Jain, Ajisha Aravindan, Pravas Chandra Mishra, Renu Saxena</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Patterns of Acquired Bleeding Disorders in a Tertiary Care Hospital]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/470?rss=1&amp;ssource=mfc">
<title><![CDATA[Potential Role of Thrombelastography in the Monitoring of Acquired Factor VIII Inhibitor Hemophilia A: Report on a 78-year-old Woman With Life-threatening Bleedings]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/470?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Luca Spiezia, Leonardo Meneghetti, Fabio Dalla Valle, Giulio Tognin, Claudia Radu, Graziella Saggiorato, Mariangela Fadin, Ezio Zanon, Paolo Simioni<br />Aug  1, 2009; 15:470-476<br />Article]]></description>
<dc:creator>Luca Spiezia, Leonardo Meneghetti, Fabio Dalla Valle, Giulio Tognin, Claudia Radu, Graziella Saggiorato, Mariangela Fadin, Ezio Zanon, Paolo Simioni</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Potential Role of Thrombelastography in the Monitoring of Acquired Factor VIII Inhibitor Hemophilia A: Report on a 78-year-old Woman With Life-threatening Bleedings]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029608322547v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Utility of the PFA-100 Instrument and the Novel Multiplate Analyzer for the Assessment of Aspirin and Clopidogrel Effects on Platelet Function in Patients With Cardiovascular Disease]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029608322547v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Thomas Mueller, Benjamin Dieplinger, Werner Poelz, Meinhard Haltmayer<br />Sep 19, 2008; 0:107602960<br />Article]]></description>
<dc:creator>Thomas Mueller, Benjamin Dieplinger, Werner Poelz, Meinhard Haltmayer</dc:creator>
<dc:date>2008-09-19</dc:date>
<dc:title><![CDATA[Utility of the PFA-100 Instrument and the Novel Multiplate Analyzer for the Assessment of Aspirin and Clopidogrel Effects on Platelet Function in Patients With Cardiovascular Disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/2/137?rss=1&amp;ssource=mfc">
<title><![CDATA[Thrombin Generation by Exposure of Blood to Endotoxin: A Simple Model to Study Disseminated Intravascular Coagulation]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/2/137?rss=1&amp;ssource=mfc</link>
<description><![CDATA[T. W. Stief<br />Apr  1, 2006; 12:137-161<br />Article]]></description>
<dc:creator>T. W. Stief</dc:creator>
<dc:date>2006-04-01</dc:date>
<dc:identifier>10.1177/107602960601200202</dc:identifier>
<dc:title><![CDATA[Thrombin Generation by Exposure of Blood to Endotoxin: A Simple Model to Study Disseminated Intravascular Coagulation]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/12/3/254?rss=1&amp;ssource=mfc">
<title><![CDATA[Thromboembolism in Cancer Patients: Pathogenesis and Treatment]]></title>
<link>http://cat.sagepub.com/cgi/content/short/12/3/254?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Matthew Adess, Robert Eisner, Sucha Nand, John Godwin, Harry L. Messmore Jr, William H. Wehrmacher<br />Jul  1, 2006; 12:254-266<br />Article]]></description>
<dc:creator>Matthew Adess, Robert Eisner, Sucha Nand, John Godwin, Harry L. Messmore Jr, William H. Wehrmacher</dc:creator>
<dc:date>2006-07-01</dc:date>
<dc:identifier>10.1177/1076029606291432</dc:identifier>
<dc:title><![CDATA[Thromboembolism in Cancer Patients: Pathogenesis and Treatment]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/14/4/385?rss=1&amp;ssource=mfc">
<title><![CDATA[Are All Low Molecular Weight Heparins Equivalent in the Management of Venous Thromboembolism?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/14/4/385?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jawed Fareed, Walter Jeske, Daniel Fareed, Melaine Clark, Rakesh Wahi, Cafer Adiguzel, Debra Hoppensteadt<br />Oct  1, 2008; 14:385-392<br />Original Articles]]></description>
<dc:creator>Jawed Fareed, Walter Jeske, Daniel Fareed, Melaine Clark, Rakesh Wahi, Cafer Adiguzel, Debra Hoppensteadt</dc:creator>
<dc:date>2008-10-01</dc:date>
<dc:identifier>10.1177/1076029608319881</dc:identifier>
<dc:title><![CDATA[Are All Low Molecular Weight Heparins Equivalent in the Management of Venous Thromboembolism?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/15/4/402?rss=1&amp;ssource=mfc">
<title><![CDATA[Are Prothrombotic Variants of Platelet Glycoprotein Receptor Polymorphisms Involved in the Pathogenesis of Thrombotic Microangiopathies?]]></title>
<link>http://cat.sagepub.com/cgi/content/short/15/4/402?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christoph Sucker, Michael Schmitz, Gerd R. Hetzel, Bernd Grabensee, Beate Maruhn-Debowski, Ljerka Ostojic, Rudiger E. Scharf, Rainer B. Zotz<br />Aug  1, 2009; 15:402-407<br />Article]]></description>
<dc:creator>Christoph Sucker, Michael Schmitz, Gerd R. Hetzel, Bernd Grabensee, Beate Maruhn-Debowski, Ljerka Ostojic, Rudiger E. Scharf, Rainer B. Zotz</dc:creator>
<dc:date>2009-08-01</dc:date>
<dc:title><![CDATA[Are Prothrombotic Variants of Platelet Glycoprotein Receptor Polymorphisms Involved in the Pathogenesis of Thrombotic Microangiopathies?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609335517v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Fibrinolytic Therapy of Prosthetic Mitral Valve Thrombosis During Pregnancy: Three Case Reports and Review of the Literature]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609335517v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Orhan Ozer, Vedat Davutoglu, Hatice E. Soydinc, Fatma B. Cebesoy, Ibrahim Sari, Murat Akcay<br />Oct 13, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Orhan Ozer, Vedat Davutoglu, Hatice E. Soydinc, Fatma B. Cebesoy, Ibrahim Sari, Murat Akcay</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[Fibrinolytic Therapy of Prosthetic Mitral Valve Thrombosis During Pregnancy: Three Case Reports and Review of the Literature]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/1076029609344085v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Assessment of the Usefulness of Antithrombin-III in the Management of Disseminated Intravascular Coagulation in Obstetrically Ill Patients]]></title>
<link>http://cat.sagepub.com/cgi/content/short/1076029609344085v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Aiko Kobayashi, Yoshio Matsuda, MD, PhD, Minoru Mitani, Yasuo Makino, Hiroaki Ohta<br />Oct 14, 2009; 0:107602960<br />Article]]></description>
<dc:creator>Aiko Kobayashi, Yoshio Matsuda, MD, PhD, Minoru Mitani, Yasuo Makino, Hiroaki Ohta</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Assessment of the Usefulness of Antithrombin-III in the Management of Disseminated Intravascular Coagulation in Obstetrically Ill Patients]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cat.sagepub.com/cgi/content/short/10/2/89?rss=1&amp;ssource=mfc">
<title><![CDATA[Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia]]></title>
<link>http://cat.sagepub.com/cgi/content/short/10/2/89?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. Akif Ozturk, Ibrahim C. Haznedaroglu, Mehmet Turgut, Hakan Goker<br />Apr  1, 2004; 10:89-126<br />Article]]></description>
<dc:creator>M. Akif Ozturk, Ibrahim C. Haznedaroglu, Mehmet Turgut, Hakan Goker</dc:creator>
<dc:date>2004-04-01</dc:date>
<dc:identifier>10.1177/107602960401000201</dc:identifier>
<dc:title><![CDATA[Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>